FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Clinical trial NCT05913037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05913037
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2025-08-19
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.